ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2025
Trends in Glycemic and Cardiovascular Risks Control in Cantonese Adults in Primary Healthcare Settings: 2018 to 2022.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Glycemic and cardiovascular risks control in patients with type 2 diabetes (T2DM) managed in primary healthcare (PHC) settings remains challenging in urbanizing areas like Guangzhou. This study analyzes 2018-2022 trends to identify care gaps and inform policy. Methods: We collected and analyzed real-world data (RWD) from 81,709 adults aged 30 years or older with T2DM who voluntarily participated in health examinations across 24 primary healthcare settings in Baiyun district, Guangzhou. The assessed targets included fasting blood glucose(FBG), blood pressure (BP), lipid panel with total cholesterol(TC), triglycerides(TG),low-density lipoprotein(LDL) and high-density lipoprotein(HDL), and BMI. Associated factors encompassed socioeconomic and lifestyle variables, and anthropometric measurement as waist circumference (WC). Linear and logistic regression models were used to analyze the trend in the percentage of participants with clinical target achievements and associated factors. Results: The study population comprised predominantly older female participants with prolonged diabetes duration and high hypertension comorbidity prevalence (87.6%).Trends in the standardized percentage of participants with control of FG, TC, TG, LDL, and BMI were improved; however, those for BP and HDL decreased from 2018 to 2022 ( Conclusion: While metabolic parameters improved, suboptimal BP and HDL control reveal ongoing primary care challenges.Advanced age, female sex, longer diabetes duration, unmarried status, and increased WC are key barriers to uncontrolled FG, BP, and LDL. The findings highlight the need to prioritize enhanced BP and HDL control strategies and implement precision lifestyle interventions for high-risk patient subgroups in PHC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.